Home Legal Ozempic Lawsuit

Ozempic Lawsuit

Ozempic lawsuits claim the drug can cause severe gastroparesis, a disorder that stops or slows the movement of food from the stomach to the small intestine. According to Ozempic lawsuits, the drug’s manufacturers never warned the public of the risk. Plaintiffs seek compensation for their injuries.

This is an active lawsuit

See If You Qualify for an Ozempic Lawsuit

If you developed severe gastroparesis, or stomach paralysis, after taking Ozempic, you may be entitled to compensation. Get a free case review today.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews

Get Your Free Case Review

  • A+BBB Rating
  • 4.9 StarGoogle Reviews
We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.
Last Modified: September 11, 2023
Fact Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us


"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Latest Ozempic Lawsuit Updates

As of August 2023, Ozempic lawsuits were still in the early stages, and there have been no global settlements or jury trials. Jaclyn Bjorklund filed one of the first Ozempic gastroparesis lawsuits in Louisiana on Aug. 2, 2023, under case number 2:23-cv-01020-JDC-KK.

Ozempic is a brand name for semaglutide and is manufactured by Novo Nordisk. Bjorklund’s lawsuit included the drug Mounjaro (tirzepatide) and named Eli Lilly, its manufacturer, as a defendant.

  • August 2023: Jaclyn Bjorklund became one of the first people to file an Ozempic and Mounjaro gastroparesis lawsuit. Summonses to Novo Nordisk and Eli Lilly were issued on Aug. 3.
  • July 2023: ASHP, the largest association of pharmacy professionals in the U.S., advised that Novo Nordisk was running short of Ozempic and Wegovy, another semaglutide, because of increased demand.
  • August 2022: Judges centralized seven Novo Nordisk lawsuits in multidistrict litigation in Delaware against generic drug makers for patent infringement. Defendants had filed U.S. Food and Drug Administration applications for approval to make generic versions of Ozempic.
  • August 2022: After scientists published a research letter in JAMA Internal Medicine linking Ozempic to a higher risk of gallbladder disease and gallstones, lawyers began accepting Ozempic gallbladder lawsuits.

So far, there haven’t been any Ozempic class-action lawsuits to demand refunds of the drug, but lawyers are accepting personal injury lawsuits for gastroparesis. Other Ozempic lawsuits include claims that the drug increases the risk of gallbladder disease.

As of August 2023, lawyers had not filed a motion to consolidate Ozempic lawsuits into multidistrict litigation. But that could change if this litigation grows.

Why Are People Filing Ozempic Lawsuits?

People filed the most recent Ozempic lawsuits because they took the drug and later suffered from gastroparesis, a severe disorder that causes food to move too slowly through the stomach to the small intestine. In some cases, food may stop moving through the intestine altogether.

Gastroparesis may cause nausea, vomiting, abdominal bloating, abdominal pain, severe dehydration, acid reflux, malnutrition and weight loss. Undigested food may remain in the stomach and harden.

Ozempic belongs to a class of drugs called GLP-1 agonists, and lawyers are also investigating gastroparesis claims for other drugs in the same class.

Other GLP-1 agonists being named in claims like Ozempic lawsuits include:
  • Mounjaro
  • Rybelsus
  • Saxenda
  • Wegovy

According to Ozempic lawsuits, since the FDA approved Ozempic in 2017, Novo Nordisk has not included gastroparesis warnings in its prescription information. The company warned about other Ozempic side effects but didn’t warn the public of the risk of severe gastroparesis.

There is no cure for gastroparesis, and plaintiffs are seeking compensation for loss of quality of life, past and future medical bills and other damages.

Injuries Named in Ozempic Lawsuits

The main injury claimed in the most recent Ozempic lawsuits is gastroparesis, or a paralyzed stomach. This causes severe vomiting that can last for four weeks or more. Gastroparesis may also occur with gastroenteritis, or stomach inflammation.

According to Bjorklund’s complaint, which combines an Ozempic lawsuit and a Mounjaro lawsuit, she had gastrointestinal problems after she used Ozempic and Mounjaro. She took Ozempic for more than a year before she stopped using it in July 2023 and switched to Mounjaro. She experienced gastroparesis that caused severe vomiting, which led to her teeth falling out.

Bjorklund was forced to visit the emergency room several times and was hospitalized with symptoms that included stomach pain, gastrointestinal burning and throwing up whole food only hours after eating. She now takes additional medications for excessive vomiting.

Are you suffering from severe gastroparesis, or stomach paralysis, after taking Ozempic?

Who Qualifies to File an Ozempic Lawsuit?

You may qualify to file an Ozempic lawsuit if you took Ozempic for weight loss or any other indication and suffered gastroparesis. At this time, lawyers are accepting cases from people who suffered severe gastroparesis resulting in vomiting for four weeks or more.

Currently, you may not qualify if you had gastric bypass surgery, gastric banding or gastric sleeve surgery before taking Ozempic. Additionally, lawyers are not taking Ozempic cases if you are being treated for cancer.

These criteria are guidelines, and only an Ozempic lawyer can tell you if you qualify to file a lawsuit. Make sure you contact a lawyer right away for a free case review and preserve your right to file a lawsuit for potential compensation. Depending on the state you live in, you may only have a limited time to file.

Choosing an Ozempic Lawyer

When choosing an Ozempic lawyer, be sure to check the law firm’s experience and track record when it comes to obtaining settlements and favorable jury verdicts in pharmaceutical lawsuits. For example, Drugwatch works with Morgan & Morgan, one of the largest national law firms in the country.

The firm has recovered $15 billion in settlements and verdicts for clients. It is currently investigating more than 500 Ozempic gastroparesis lawsuits for clients in 45 states.

“Ms. Bjorklund put her trust in Novo Nordisk and Eli Lilly and Company, and we believe that as a result she has gone through a hell that no one should have to endure.”
Paul Pennock, partner at Morgan & Morgan

“Ms. Bjorklund put her trust in Novo Nordisk and Eli Lilly and Company, and we believe that as a result she has gone through a hell that no one should have to endure,” Morgan & Morgan partner Paul Pennock said in a statement. “Ms. Bjorklund, as well as the over 500 clients across 45 states whose claims we continue to investigate, have suffered ongoing gastrointestinal problems that in many cases are severe, debilitating and disabling. Some of the injuries may be permanent.”

For many people injured through no fault of their own after taking Ozempic, filing a lawsuit can hold companies accountable for their alleged failure to warn patients about these serious side effects, Pennock added.

Please seek the advice of a medical professional before making health care decisions.